vaccine

New malaria vaccine doesn't work most of the time, but manufacturer says it's good enough to sell


Most Viewed Articles
Popular on Facebook
The five biggest lies about Ebola being pushed by government and mass media
White House admits staging fake vaccination operation to gather DNA from the public
Why does the CDC own a patent on Ebola 'invention?'
Ultraviolet light robot kills Ebola in two minutes; why doesn't every hospital have one of these?
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Russia taking McDonald's to court, threatens countrywide shutdown
Oregon man serving prison sentence for collecting rainwater on his own property
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Global warming data FAKED by government to fit climate change fictions
Healthy 12-year-old girl dies shortly after receiving HPV vaccine
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Ebola outbreak may already be uncontrollable; Monsanto invests in Ebola treatment drug company as pandemic spreads
Ben & Jerry's switches to non-GMO, Fair Trade ice cream ingredients
W.H.O. contradicts CDC, admits Ebola can spread via coughing, sneezing and by touching contaminated surfaces
Elliot Rodger, like nearly all young killers, was taking psychiatric drugs (Xanax)
BREAKING: CDC whistleblower confesses to MMR vaccine research fraud in historic public statement

Delicious
(NaturalNews) There's a good chance that the vast majority of people who receive it won't derive any benefits whatsoever. But that isn't stopping British drug giant GlaxoSmithKline (GSK) from seeking regulatory approval for a new vaccine for malaria, known as RTS,S, that a recent study determined is only about 30 percent effective at preventing severe cases of the disease, which has no recognized cure.

Published in the journal PLOS Medicine, the study found that RTS,S provides limited protection in select individuals for up to a year-and-a-half, at most. In children five to 17 years of age, the vaccine can supposedly prevent infection up to 46 percent of the time, and severe infection up to 34 percent of the time. These figures, claim GSK, are good enough to warrant the drug's approval, even though no other vaccine with such a poor success record has ever been approved.

"It's a pretty good vaccine," stated Mary Hamel, a medical epidemiologist at the U.S. Centers for Disease Control and Prevention (CDC), one of the authors of the new study. "We were looking for 30 percent or higher."

High cost, limited efficacy suggest RTS,S is a medical scam

Since malaria reportedly kills about 600,000 people every year, GSK and its allies believe that even limited success is enough to excuse the failures of RTS,S -- just think of the children! Except this tired excuse isn't really working this time around, as many are asking how the nations of the world will be able to pay for this hit-or-miss jab, which appears to require constant booster shots just to remain even minimally effective.

Not only that, RTS,S is even less effective on young children between the ages of six and 12 weeks old. For these young ones, who are more prone than others to contracting malaria, RTS,S maybe offers a 27 percent success rate, which in efficacy terms is exceptionally poor. And for those who do benefit from the vaccine, regular booster shots are necessary to maintain immunity.

"Who is going to pay to deliver this vaccine, which is not a cheap vaccine to manufacture?" asked Dr. Jonathan Kurtis from Brown University, as quoted by VOA News. "Will they pay to stop 20 cases per 1000 participants per year and a half? I can't answer that."

Majority of those threatened by malaria death won't even benefit from RTS,S

Interestingly, those who are most prone to dying from malaria -- children under the age of five -- are the least likely to benefit from RTS,S, as admitted in the study. While adults have the highest rate of protection at about 45 percent, young children have about a one in four chance of avoiding the disease. At the same time, they face potential adverse events from the vaccine and its various toxic adjuvants and other additives.

As you will notice in this GSK information sheet [PDF], RTS,S is also a product of the Bill & Melinda Gates Foundation, which has admittedly spent hundreds of millions of dollars pushing its development. According to the same sheet, GSK will have spent more than half-a-billion dollars on RTS,S when all is said and done.

Sources for this article include:

http://www.voanews.com

http://vaccinenewsdaily.com

http://www.pharmabiz.com

http://www.malariavaccine.org [PDF]

http://www.plosmedicine.org

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.